查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1666186

全球穿戴式腦電圖監測儀市場 - 2025 至 2033 年

Global Wearable EEG Monitors Market - 2025-2033
出版日期: | 出版商: DataM Intelligence | 英文 220 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球穿戴式腦電圖監測設備市場規模達到 2.7257 億美元，預計到 2033 年將達到 6.9288 億美元，在 2025-2033 年預測期內的複合年成長率為 10.8%。

穿戴式腦電圖設備是一種輕巧、無線且舒適的系統，可透過放置在頭皮上的電極來測量和記錄大腦活動。它們在醫療保健領域用於診斷神經系統疾病、追蹤精神狀態和監測大腦活動。它們在研究、認知研究、心理健康和 BCI 應用中也很受歡迎，可提供即時資料以增強臨床結果和消費者健康洞察。

市場動態：

促進因素與約束因素

神經系統疾病盛行率不斷上升

全球穿戴式腦電圖監測儀市場的發展受到癲癇、阿茲海默症、帕金森氏症和中風等神經系統疾病日益流行的推動。這些情況需要持續監測大腦活動，以便早期診斷、制定治療計劃和追蹤疾病進展。穿戴式腦電圖設備為即時腦電波監測提供了一種非侵入性、便捷的解決方案，減少了去醫院的次數。隨著人口老化和生活方式因素的增加，對先進的腦電圖監測解決方案的需求預計會增加。此外，人們對憂鬱和焦慮等心理健康狀況的認知不斷提高，擴大了穿戴式腦電圖設備的應用。

例如，根據帕金森基金會的數據，帕金森氏症影響了美國 100 萬人，預計到 2030 年將上升到 120 萬人。 帕金森氏症是繼阿茲海默症之後第二常見的神經退化性疾病，影響了美國 9 萬人和全球超過 1000 萬人。此疾病的發生率會隨著年齡的成長而增加，估計有 4% 的患者在 50 歲之前就被診斷出來。

高級穿戴式腦電圖設備成本高昂

全球先進穿戴式腦電圖設備市場因成本高昂（包括高昂的生產和零售價格）而面臨挑戰。這些設備採用了無線應用和基於人工智慧的分析等先進技術，價格昂貴，可能超出了中低收入地區的醫療機構和患者的承受範圍。對於需要長期神經監測的人來說，家庭腦電圖監測解決方案在經濟上可能也是難以承受的。這種財務障礙阻礙了市場擴張。

目錄

第 1 章：方法與範圍

第 2 章：定義與概述

第 3 章：執行摘要

第 4 章：動態

  • 影響因素
    • 驅動程式
      • 神經系統疾病盛行率不斷上升
    • 限制
      • 高級穿戴式腦電圖設備成本高昂
    • 機會
    • 影響分析

第5章：戰略洞察與產業展望

  • 市場領導者和先驅者
    • 新興先鋒和傑出參與者
    • 擁有最大銷售品牌的成熟領導者
    • 擁有成熟產品的市場領導者
  • CXO 觀點
  • 最新進展與突破
  • 案例研究/正在進行的研究
  • 監管和報銷情況
    • 北美洲
    • 歐洲
    • 亞太地區
    • 拉丁美洲
    • 中東和非洲
  • 波特五力分析
  • 供應鏈分析
  • 專利分析
  • SWOT 分析
  • 未滿足的需求和差距
  • 市場進入和擴張的推薦策略
  • 情境分析：最佳情況、基本情況和最壞情況預測
  • 定價分析和價格動態
  • 關鍵意見領袖

第 6 章：依產品類型

  • 頭帶
  • 耳部腦電圖設備
  • 其他

第 7 章：按頻道

  • 5通道腦電圖
  • 14 通道腦電圖
  • 32通道腦電圖

第 8 章：按應用

  • 創傷與外科
  • 疾病診斷
  • 麻醉監測
  • 睡眠監測
  • 其他

第 9 章：按最終用戶

  • 醫院
  • 診所
  • 研究機構
  • 家庭護理設置

第 10 章：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 西班牙
    • 義大利
    • 歐洲其他地區
  • 南美洲
    • 巴西
    • 阿根廷
    • 南美洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 中東和非洲

第 11 章：競爭格局

  • 競爭格局
  • 市場定位/佔有率分析
  • 併購分析

第 12 章：公司簡介

  • BrainScope Company, Inc
    • 公司概況
    • 產品組合
      • 產品描述
      • 產品關鍵績效指標 (KPI)
      • 歷史和預測產品銷售量
      • 產品銷售量
    • 財務概覽
      • 公司收入
      • 地區收入佔有率
      • 收入預測
    • 主要進展
      • 合併與收購
      • 關鍵產品開發活動
      • 監管部門批准等
    • SWOT 分析
  • NeuroSky
  • Compumedics Limited
  • Emotiv
  • Advanced Brain Monitoring
  • Wearable Sensing
  • Interaxon Inc
  • Cognionics, Inc.
  • Mitsar Co. Ltd.
  • BitBrain Technologies
  • Similar data will be provided for each market player.
  • Neurable
    • 管道產品描述
    • 產品關鍵績效指標 (KPI)
    • 主要活動
    • 市場進入時間表
    • 產品滲透率
    • 銷售估計和預測
  • 開放BCI
  • 神經電學
  • 腦產品有限公司
  • 思維迷宮
  • 核心
  • 將為每個市場參與者提供類似的資料。

第 13 章：附錄

簡介目錄
Product Code: MD9201

The Global Wearable EEG Monitors Market reached US$ 272.57 Million in 2024 and is expected to reach US$ 692.88 Million by 2033, growing at a CAGR of 10.8% during the forecast period 2025-2033.

Wearable EEG devices are lightweight, wireless, and comfortable systems that measure and record brain activity through electrodes placed on the scalp. They are used in healthcare for diagnosing neurological disorders, tracking mental states, and monitoring brain activity. They are also popular in research, cognitive studies, mental wellness, and BCI applications, providing real-time data to enhance clinical outcomes and consumer health insights.

Market Dynamics: Drivers & Restraints

Increasing Prevalence of Neurological Disorders

The global wearable EEG monitors market is driven by the increasing prevalence of neurological disorders like epilepsy, Alzheimer's, Parkinson's, and stroke. These conditions require continuous brain activity monitoring for early diagnosis, treatment planning, and disease progression tracking. Wearable EEG devices offer a non-invasive, convenient solution for real-time brain wave monitoring, reducing hospital visits. As aging populations and lifestyle factors increase, demand for advanced EEG monitoring solutions is expected to grow. Additionally, increasing awareness of mental health conditions like depression and anxiety expands the application of wearable EEG devices.

For instance, according to Parkinson's Foundation, Parkinson's disease affects one million people in the U.S. and is expected to rise to 1.2 million by 2030. The second-most common neurodegenerative disease after Alzheimer's, it affects 90,000 people in the U.S. and over 10 million people worldwide. The disease increases with age, with an estimated 4% diagnosed before age 50. Men are 1.5 times more likely to have Parkinson's disease.

High Costs associated with Advanced Wearable EEG Devices

The global market for advanced wearable EEG devices faces challenges due to high costs, including high production and retail prices. These devices, which incorporate advanced technologies like wireless Application and AI-based analytics, are expensive and may be out of reach for healthcare institutions and patients in low- and middle-income regions. Home-based EEG monitoring solutions may also be financially out of reach for those requiring long-term neurological monitoring. This financial barrier hinders market expansion.

Segment Analysis

The global Wearable EEG Monitors market is segmented based on Product Type, Channel, Application, End User and Region.

Product Type:

Headbands segment is expected to dominate the Wearable EEG Monitors market share

The headbands segment holds a major portion of the Wearable EEG Monitors market share and is expected to continue to hold a significant portion of the Wearable EEG Monitors market share during the forecast period.

Headbands are a key player in the wearable EEG monitor market, offering a comfortable, user-friendly, and non-invasive method for continuous brain activity monitoring. They are used in neurofeedback, cognitive research, mental wellness tracking, and sleep studies. Their portability and ease of use reduce reliance on traditional EEG systems. The integration of AI and wireless technology enhances their accuracy and real-time data transmission, making them popular in medical and consumer applications.

For instance, in May 2024, Neurotechnology has upgraded its BrainAccess HALO headband, a dry-contact EEG solution, with a 4-channel system and Bluetooth connectivity. The new headband is smaller, lighter, and more mechanically flexible, allowing better adaptation to different head shapes. It also features semi-flexible back electrodes with softer springs.

End User:-

Hospitals segment is the fastest-growing segment in Wearable EEG Monitors market share

The hospitals segment is the fastest-growing segment in the Wearable EEG Monitors market share and is expected to hold the market share over the forecast period.

Hospitals are a major user of wearable EEG monitors, primarily used for diagnosing and managing neurological disorders like epilepsy, stroke, and brain injuries. These devices offer an efficient, patient-friendly alternative to traditional wired EEG systems, allowing continuous monitoring without restricting patient movement. They are also used in ICUs and emergency settings for rapid brain activity assessment. Wearable EEG solutions facilitate remote patient monitoring, enabling early intervention and improved disease management.

Geographical Analysis

North America is expected to hold a significant position in the Wearable EEG Monitors market share

North America holds a substantial position in the Wearable EEG Monitors market and is expected to hold most of the market share due to its high prevalence of neurological disorders like epilepsy, Alzheimer's, and Parkinson's. The region benefits from advanced healthcare infrastructure, digital health technologies, and strong neuroscience research. Consumer awareness of mental health and cognitive wellness drives demand for EEG devices, and government support and favorable reimbursement policies further stimulate market growth.

For instance, in January 2025, Emotiv has introduced its next-generation EEG Active Noise-Cancelling Earphones, which integrate advanced EEG technology to provide insights into cognitive performance and overall well-being. The MW20, built on Emotiv's MN8 earphones, offers premium audio and neurotechnology to deliver actionable wellness insights and BCI capabilities in an intuitive form factor. The earphones are made of machined aluminum and sapphire glass, featuring an ergonomic design for optimal fit and precise acoustics.

Europe is growing at the fastest pace in the Wearable EEG Monitors market

Europe holds the fastest pace in the Wearable EEG Monitors market and is expected to hold most of the market share due to rising healthcare costs, rise in the prevalence of neurological disorders, and home-based monitoring. The region emphasizes early diagnosis and preventive healthcare, encouraging the use of wearable EEG devices. Technological advancements, research initiatives, and collaborations between academic institutions and medical device companies contribute to market expansion. Awareness of neurofeedback therapy and supportive regulatory frameworks further fuel this growth.

For instance, Parkinson's is the fastest-growing neurological condition globally, with 153,000 people living with it in the UK. By 2030, the number is expected to rise to 172,000 due to population growth and ageing. Every hour, 2 more people are diagnosed, equivalent to 18,000 people annually.

Hence, the increasing prevalence of Parkinson's and other neurodegenerative disorders is driving the demand for advanced neurological monitoring solutions, such as wearable EEG monitors. These devices enable real-time brain activity tracking, early detection of abnormalities, and remote patient monitoring, enhancing Parkinson's management and treatment.

Competitive Landscape

The major global players in the Wearable EEG Monitors market include BrainScope Company, Inc, NeuroSky, Compumedics Limited, Emotiv, Advanced Brain Monitoring, Wearable Sensing, Interaxon Inc, Cognionics, Inc, Mitsar Co. Ltd., BitBrain Technologies sand among others.

Key Developments

  • In September 2024, Neurable Inc. and Master & Dynamic have launched the MW75 Neuro smart headphones, which integrate with Neurable's brain-computer interface (BCI) technology. These headphones provide users with deeper insights into their cognitive health, help manage burnout, and enhance daily performance. As the first BCI-enabled consumer-grade device, they empower users to control their health and well-being through their minds.
  • In April 2024, Soterix Medical Inc. has launched the MxN-GO EEG, a non-invasive brain stimulation and synergistic monitoring system. This lightweight, wire-free system is designed for research applications requiring electrical stimulation and recording of brain activity in mobile and natural environments. With 33 stimulation and 32 recording channels, it offers unparalleled precision and application-specific targeting.

Why Purchase the Report?

  • Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
  • Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
  • Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
  • Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
  • Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
  • Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
  • Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
  • Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
  • Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
  • Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
  • Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
  • Post-market Surveillance: Uses post-market data to enhance product safety and access.
  • Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global Wearable EEG Monitors market report delivers a detailed analysis with 61 key tables, more than 59 visually impactful figures, and 220 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

  • Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
  • Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
  • Product Type & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
  • Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
  • Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
  • Supply Chain: Distribution and Supply Chain Managers.
  • Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
  • Academic & Research: Academic Institutions.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product Type
  • 3.2. Snippet by Channel
  • 3.3. Snippet by Application
  • 3.4. Snippet by End User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Neurological Disorders
    • 4.1.2. Restraints
      • 4.1.2.1. High Costs associated with Advanced Wearable EEG Devices
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Strategic Insights and Industry Outlook

  • 5.1. Market Leaders and Pioneers
    • 5.1.1. Emerging Pioneers and Prominent Players
    • 5.1.2. Established leaders with largest selling Brand
    • 5.1.3. Market leaders with established Product
  • 5.2. CXO Perspectives
  • 5.3. Latest Developments and Breakthroughs
  • 5.4. Case Studies/Ongoing Research
  • 5.5. Regulatory and Reimbursement Landscape
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa
  • 5.6. Porter's Five Force Analysis
  • 5.7. Supply Chain Analysis
  • 5.8. Patent Analysis
  • 5.9. SWOT Analysis
  • 5.10. Unmet Needs and Gaps
  • 5.11. Recommended Strategies for Market Entry and Expansion
  • 5.12. Scenario Analysis: Best-Case, Base-Case, and Worst-Case Forecasts
  • 5.13. Pricing Analysis and Price Dynamics
  • 5.14. Key Opinion Leaders

6. By Product Type

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 6.1.2. Market Attractiveness Index, By Product Type
  • 6.2. Headbands*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Ear EEG Devices
  • 6.4. Others

7. By Channel

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel
    • 7.1.2. Market Attractiveness Index, By Channel
  • 7.2. 5 Channel EEG*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. 14 Channel EEG
  • 7.4. 32 Channel EEG

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Trauma & Surgery*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Disease Diagnosis
  • 8.4. Anesthesia Monitoring
  • 8.5. Sleep Monitoring
  • 8.6. Others

9. By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Clinics
  • 9.4. Research Institutions
  • 9.5. Homecare Settings

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. U.K.
      • 10.3.7.3. France
      • 10.3.7.4. Spain
      • 10.3.7.5. Italy
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Channel
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

Key Market Players

  • 12.1. BrainScope Company, Inc*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio
      • 12.1.2.1. Product Description
      • 12.1.2.2. Product Key Performance Indicators (KPIs)
      • 12.1.2.3. Historic and Forecasted Product Sales
      • 12.1.2.4. Product Sales Volume
    • 12.1.3. Financial Overview
      • 12.1.3.1. Company Revenue's
      • 12.1.3.2. Geographical Revenue Shares
      • 12.1.3.3. Revenue Forecasts
    • 12.1.4. Key Developments
      • 12.1.4.1. Mergers & Acquisitions
      • 12.1.4.2. Key Product Development Activities
      • 12.1.4.3. Regulatory Approvals etc.
    • 12.1.5. SWOT Analysis
  • 12.2. NeuroSky
  • 12.3. Compumedics Limited
  • 12.4. Emotiv
  • 12.5. Advanced Brain Monitoring
  • 12.6. Wearable Sensing
  • 12.7. Interaxon Inc
  • 12.8. Cognionics, Inc.
  • 12.9. Mitsar Co. Ltd.
  • 12.10. BitBrain Technologies
  • Similar data will be provided for each market player.

Emerging Market Players

  • 12.11. Neurable*
    • 12.11.1. Pipeline Products Description
    • 12.11.2. Product Key Performance Indicators (KPIs)
    • 12.11.3. Key Activities
    • 12.11.4. Market Entry Timelines
    • 12.11.5. Product Penetration Rate
    • 12.11.6. Sales Estimation and Projections
  • 12.12. OpenBCI
  • 12.13. Neuroelectrics
  • 12.14. Brain Products GmbH
  • 12.15. MindMaze
  • 12.16. Kernel
  • Similar data will be provided for each market player.

LIST NOT EXHAUSTIVE

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us